Granulo-monocyto apheresis is more effective in mild ulcerative colitis than in moderate to severe disease.

Chiara De Cassan¹, Edoardo Savarino¹, Piero Marson¹, Tiziana Tison¹, Giorgia Hatem¹, Giacomo Carlo Sturniolo¹, Renata D’Incà¹ , World J Gastroenterol. 2014 Dec 7;20(45):17155-62.

Patients with mild UC benefit from GMA more than patients with moderate to severe disease in the short-term period. GMA should be considered a valid therapeutic option in cases of contraindications to immunosuppressants, corticosteroids and/or biologics.

https://pubmed.ncbi.nlm.nih.gov/25493030/

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4258586/pdf/WJG-20-17155.pdf